Metamizol Aristo (Metamizole Sodium Monohydrate)

Metamizole sodium works by inhibiting cyclo‑oxygenase enzymes, which lowers prostaglandin production. It also influences inflammatory pathways and neuronal signaling, leading to decreased pain perception and a reduction in body temperature without strong peripheral anti‑inflammatory effects.

The appropriate dose of Metamizol Aristo is determined by the prescribing healthcare professional based on the individual’s condition, severity of symptoms, age, and renal or hepatic function. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for metamizole sodium in pregnancy and lactation are limited, and the product’s pregnancy category is not established. Healthcare providers should weigh potential benefits against risks before prescribing it to pregnant or nursing women.

To order Metamizol Aristo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metamizole sodium belongs to the pyrazolone class, offering analgesic and antipyretic effects similar to NSAIDs but with a distinct safety profile. Compared with traditional NSAIDs, it may have a lower risk of gastrointestinal irritation but carries a rare risk of agranulocytosis, requiring blood‑count monitoring.

Metamizol Aristo should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture. Keep the product away from direct sunlight and out of reach of children.

Metamizol Aristo is formulated for oral administration. The tablets or oral solution should be taken with water as directed by the prescriber, usually with or without food, depending on individual tolerance and the specific clinical situation.

The most serious risks include agranulocytosis, a potentially life‑threatening drop in white blood cells, and severe skin reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if signs of infection, unexplained fever, or skin changes occur.

Metamizol Aristo should be avoided in individuals with known hypersensitivity to metamizole or other pyrazolones, in patients with a history of agranulocytosis, and in those with severe liver or kidney impairment unless closely monitored by a physician.